Relay Therapeutics (RLAY) Insider Trading & Ownership → Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad) Free RLAY Stock Alerts $7.90 +0.63 (+8.67%) (As of 06/7/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Relay Therapeutics (NASDAQ:RLAY) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.32%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$415,926.01 Get RLAY Insider Trade Alerts Want to know when executives and insiders are buying or selling Relay Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RLAY Insider Buying and Selling by Quarter Ad Brooks EnterprisesWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, was terrible! The majority of market indexes lost over 50% of their value. Almost every day, traders would look at their trading accounts and just see a sea of red.Get those kind of results during the Great Financial Crisis, without having to study more Relay Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/5/2024Peter RahmerInsiderSell20,450$7.06$144,377.00 6/3/2024Peter RahmerInsiderSell19,864$6.47$128,520.08 4/29/2024Peter RahmerInsiderSell1,345$6.38$8,581.10 4/29/2024Thomas CatinazzoCFOSell1,695$6.38$10,814.10 3/27/2024Donald A BergstromInsiderSell765$7.70$5,890.50 3/27/2024Thomas CatinazzoCFOSell348$7.70$2,679.60 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/29/2024Peter RahmerInsiderSell1,651$9.64$15,915.64 1/29/2024Thomas CatinazzoCFOSell2,005$9.64$19,328.20 12/27/2023Peter RahmerInsiderSell244$11.51$2,808.44 12/27/2023Thomas CatinazzoCFOSell294$11.51$3,383.94 10/30/2023Peter RahmerInsiderSell1,354$6.03$8,164.62 10/30/2023Thomas CatinazzoCFOSell1,697$6.03$10,232.91 9/27/2023Donald A BergstromInsiderSell648$8.38$5,430.24 9/27/2023Thomas CatinazzoCFOSell294$8.38$2,463.72 7/28/2023Peter RahmerInsiderSell1,352$11.80$15,953.60 7/28/2023Thomas CatinazzoCFOSell1,693$11.80$19,977.40 7/12/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$12.97$1,001 - $15,0006/27/2023Donald A BergstromInsiderSell647$12.12$7,841.64 6/27/2023Thomas CatinazzoCFOSell294$12.12$3,563.28 (Data available from 1/1/2013 forward) RLAY Insider Trading Activity - Frequently Asked Questions Who is on Relay Therapeutics's Insider Roster? The list of insiders at Relay Therapeutics includes Andy Porter, Brian Adams, Donald A Bergstrom, Mark Murcko, Peter Rahmer, Sanjiv Patel, and Thomas Catinazzo. Learn more on insiders at RLAY. What percentage of Relay Therapeutics stock is owned by insiders? 4.32% of Relay Therapeutics stock is owned by insiders. Learn more on RLAY's insider holdings. Which Relay Therapeutics insiders have been selling company stock? The following insiders have sold RLAY shares in the last 24 months: Andy Porter ($24,646.11), Brian Adams ($206,562.62), Donald A Bergstrom ($1,249,802.58), Mark Murcko ($748,750.00), Peter Rahmer ($353,084.04), Sanjiv Patel ($2,345,700.00), and Thomas Catinazzo ($955,629.73). How much insider selling is happening at Relay Therapeutics? Insiders have sold a total of 294,201 Relay Therapeutics shares in the last 24 months for a total of $5,884,175.08 sold. Which members of congress are trading Relay Therapeutics? Daniel S. Goldman (D-NY) has sold shares of Relay Therapeutics in the last year totaling $8,000. More Insider Trading Tools from MarketBeat Related Companies: ALLO Insider Selling FATE Insider Selling SWTX Insider Selling APGE Insider Selling ACLX Insider Selling IOVA Insider Selling DNLI Insider Selling TWST Insider Selling VCEL Insider Selling IMCR Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Top 4 Stocks With Notable Insider Buying3 Small Cap Tech Stocks That Insiders Are Buying3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying This page (NASDAQ:RLAY) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredWarren Buffett & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relay Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relay Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.